Your browser doesn't support javascript.
loading
Deaths during tuberculosis treatment among paediatric patients in a large tertiary hospital in Nigeria.
Adamu, Aishatu L; Aliyu, Muktar H; Galadanci, Najiba Aliyu; Musa, Baba Maiyaki; Gadanya, Muktar A; Gajida, Auwalu U; Amole, Taiwo G; Bello, Imam W; Gambo, Safiya; Abubakar, Ibrahim.
Afiliação
  • Adamu AL; Department of Community Medicine, College of Health Sciences, Bayero University Kano, Kano, Nigeria.
  • Aliyu MH; Department of Community Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Galadanci NA; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
  • Musa BM; Vanderbilt Institute of Global Health, Nashville, TN, United States of America.
  • Gadanya MA; Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Gajida AU; Department of Medicine, College of Health Sciences, Bayero University Kano, Kano, Nigeria.
  • Amole TG; Department of Community Medicine, College of Health Sciences, Bayero University Kano, Kano, Nigeria.
  • Bello IW; Department of Community Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Gambo S; Department of Community Medicine, College of Health Sciences, Bayero University Kano, Kano, Nigeria.
  • Abubakar I; Department of Community Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
PLoS One ; 12(8): e0183270, 2017.
Article em En | MEDLINE | ID: mdl-28817675
ABSTRACT

BACKGROUND:

Despite availability of effective cure, tuberculosis (TB) remains a leading cause of death in children. In many high-burden countries, childhood TB is underdiagnosed and underreported, and care is often accessed too late, resulting in adverse treatment outcomes. In this study, we examined the time to death and its associated factors among a cohort of children that commenced TB treatment in a large treatment centre in northern Nigeria.

METHODS:

This is a retrospective cohort study of children that started TB treatment between 2010 and 2014. We determined mortality rates per 100 person-months of treatment, as well as across treatment and calendar periods. We used Cox proportional hazards regression to determine adjusted hazard ratios (aHR) for factors associated with mortality.

RESULTS:

Among 299 children with a median age 4 years and HIV prevalence of 33.4%; 85 (28.4%) died after 1,383 months of follow-up. Overall mortality rate was 6.1 per 100 person-months. Deaths occurred early during treatment and declined from 42.4 per 100 person-months in the 1st week of treatment to 2.2 per 100 person-months after at the 3rd month of treatment. Mortality was highest between October to December period (9.1 per 100 pm) and lowest between July and September (2.8 per 100 pm). Risk factors for mortality included previous TB treatment (aHR 2.0495%CI;1.09-3.84); HIV infection (aHR 1.6695%CI;1.02-2.71), having either extra-pulmonary disease (aHR 2.2195%CI;1.26-3.89) or both pulmonary and extrapulmonary disease (aHR 3.0395%CI;1.70-5.40).

CONCLUSIONS:

Mortality was high and occurred early during treatment in this cohort, likely indicative of poor access to prompt TB diagnosis and treatment. A redoubling of efforts at improving universal health coverage are required to achieve the End TB Strategy target of zero deaths from TB.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Centros de Atenção Terciária / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans País como assunto: Africa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Centros de Atenção Terciária / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans País como assunto: Africa Idioma: En Ano de publicação: 2017 Tipo de documento: Article